Americans considering trips to some of the world’s most dangerous destinations are being urged to take extraordinary precautions, including preparing wills, setting contingency plans and leaving DNA samples with trusted parties before departure, according to recently updated United States government travel guidance.

Get the latest news straight to your inbox!

US issues stark guidance on wills and DNA for high-risk travel

High-risk advisories highlight worst-case scenarios

Recent updates to US travel advisories for a handful of high-risk countries outline a level of preparation that goes well beyond routine pre-trip checklists. Publicly available information indicates that in at least one such advisory, travelers are encouraged to put their affairs in order before departure, including drafting or updating a will, designating power of attorney and documenting funeral wishes. The same guidance points travelers to contingency planning in case of kidnapping, detention or death abroad.

Coverage of the Libya travel advisory notes that the language is among the strongest used by the State Department, asking Americans to reconsider travel entirely and to prepare legal and personal documentation in case of emergency. One media summary highlights that Americans contemplating travel there are advised to arrange for a trusted contact at home who can act on their behalf if they are unreachable or harmed while abroad. ([inshorts.com](https://inshorts.com/en/news/us-asks-americans-to-leave-dna-samples--prepare-will-before-travelling-to-libya-1788665298079?utm_source=openai))

In parallel, commentary on broader US travel guidance underscores that these recommendations are not aimed at typical leisure destinations. Instead, they appear in the context of level 4 “do not travel” or similar high-threat warnings, where conflict, terrorism, lawlessness or state collapse significantly raises the risk that consular support may be limited or delayed. Such guidance reflects the reality that in certain environments, emergency response and remains identification can be complex and time-consuming.

Why DNA samples are entering the travel conversation

Alongside guidance on wills and emergency contacts, some recent coverage points to a more unusual recommendation: leaving a DNA sample with a medical professional or other trusted custodian before traveling to specific high-risk countries. According to published reporting, this step is framed as a way to help families and officials identify remains if a traveler is killed or goes missing in a context where traditional documentation is unavailable. ([thetraveler.org](https://www.thetraveler.org/us-travel-advisories-urge-wills-dna-prep-for-high-risk-trips/?utm_source=openai))

While DNA sampling is long established in immigration and law enforcement contexts, its appearance in consumer-facing travel guidance is relatively new. Existing federal materials describe DNA as a reliable tool for confirming biological relationships in immigration and citizenship cases, and US embassies already coordinate collection in some of those situations. In high-risk travel settings, similar identification techniques may be used after disasters, attacks or disappearances when visual recognition or paper records are insufficient. ([travel.state.gov](https://travel.state.gov/content/travel/en/us-visas/immigrate/family-immigration/dna-relationship-testing-procedures.html?utm_source=openai))

Travel security analysts note that the suggestion to leave a DNA sample does not imply that such an outcome is likely for most travelers. Rather, it is a recognition that in conflict zones and failed states, incidents can occur without witnesses, formal records or access to local forensic services. Having biometric data stored safely at home can reduce uncertainty for relatives if worst-case scenarios unfold.

What this means for travelers assessing risk

For US citizens planning international trips, the appearance of language about wills and DNA samples offers a stark signal about relative risk levels. Government advisories already grade destinations on a four-tier scale, from “exercise normal precautions” to “do not travel.” When guidance escalates to recommending end-of-life planning, commentators say it effectively communicates that the government’s ability to assist may be limited if the situation on the ground deteriorates further. ([travel.state.gov](https://travel.state.gov/content/travel/en/legal/travel-legal-considerations.html?utm_source=openai))

Travel industry observers point out that very few leisure or business destinations fall into the category where such extreme preparations are mentioned. Most countries with high visitor numbers from the United States remain in lower advisory tiers, where standard precautions such as registering with the Smart Traveler Enrollment Program, purchasing travel insurance and sharing itineraries with family are emphasized instead of biometric contingencies. ([travel.state.gov](https://travel.state.gov/en/international-travel/travel-advisories/smart-traveler-enrollment-program.html?utm_source=openai))

For individual travelers, the new language underscores the importance of reading destination-specific advisories in full rather than relying solely on headline levels. Two countries with the same overall rating may face different types of risks, from crime or civil unrest to limited medical infrastructure. Understanding whether a destination’s advisory includes recommendations about legal and biometric preparations can help travelers decide whether a trip is essential and, if so, how to prepare responsibly.

Practical steps for Americans considering high-risk trips

Legal practitioners and security consultants who comment on international travel risk generally recommend that any American contemplating travel to a level 4 or similar advisory destination take several concrete steps. These typically include preparing or updating a will, verifying beneficiaries on insurance and retirement accounts, and documenting preferences about medical decision-making in case of incapacitation abroad. Published federal guidance also stresses the value of having a designated point of contact at home who knows where key documents are stored. ([travel.state.gov](https://travel.state.gov/content/travel/en/legal/travel-legal-considerations.html?utm_source=openai))

Where advisories or news coverage mention DNA, the suggestion is usually to arrange this through a health care provider or accredited laboratory rather than consumer genetic testing kits. Existing federal resources on legal and consular matters highlight that formal identification processes rely on secure handling of biological material and medical records, particularly in cross-border contexts. In practice, this could mean leaving a sample with a physician or facility that follows established biospecimen protocols, and ensuring family members know how to access that information in an emergency. ([travel.state.gov](https://travel.state.gov/content/travel/en/us-visas/immigrate/family-immigration/dna-relationship-testing-procedures.html?utm_source=openai))

Experts also encourage travelers to consider whether their trip is essential when guidance reaches such a high level of caution. For many, alternatives such as postponing travel, choosing a lower-risk destination or conducting business remotely may be preferable to accepting the kind of risks that justify advice about wills and DNA. For those who must go, preparing thoroughly can reduce uncertainty for loved ones even if it does not change conditions on the ground.

Balancing personal freedom, privacy and security

The emergence of DNA-related recommendations within travel advisories adds a new dimension to ongoing debates about biometric data, privacy and state responsibilities. Policymakers have been scrutinizing the collection and protection of Americans’ genetic information in contexts ranging from law enforcement databases to research biobanks, with hearings and policy initiatives focused on preventing misuse by foreign or domestic actors. Travel-related guidance that touches on DNA sits at the intersection of these concerns and the government’s duty of care to citizens abroad. ([gao.gov](https://www.gao.gov/products/gao-23-106252?utm_source=openai))

Privacy advocates observe that, in contrast to mandatory DNA collection at some borders or in criminal justice settings, the context described in high-risk travel advisories is framed as voluntary and intended to remain in private hands. The recommendation is for individuals to leave samples with trusted professionals or family contacts rather than with government agencies. Even so, discussions about how such data is stored, who can access it and under what conditions it might be shared are likely to continue as biometric technologies become more common in both security and consumer applications.

For now, the presence of language about wills and DNA in a small number of extreme-risk advisories functions primarily as a signal to travelers. It serves as a reminder that not all foreign trips carry the same level of danger, and that in some environments, preparation extends into deeply personal territory. Americans weighing visits to these destinations face a choice between the freedom to travel and an acceptance of risks that government guidance now spells out in unusually stark terms.

US State Department Travel Advisories

Smart Traveler Enrollment Program (STEP)

US travel legal considerations and emergency planning

Media coverage of Libya advisory on wills and DNA